iCAD adds to revenues in 2003, as it adapts to life with CADx Medical Systems

Net sales increased to $6.5 million last year, compared with $5 million in 2002. The company also reported a net loss of $8.4 million, compared with a net loss of $9.4 million in 2002. The loss included approximately $3 million in non-recurring legal and related expenses associated with the resolution of patent litigation; a $1.4 million one-time, non-cash charge associated with the restructuring and improvement of the company's product distribution channels; and costs related to channel development and merger activities.

iCAD merged with CADx Systems Inc. and its parent company, Qualia Computing Inc., on Dec. 31, 2003.

iCAD President and CEO W. Scott Parr said the company does "not believe that iCAD's reported results for the fourth quarter or full year 2003 are indicative of the company's future prospects."

Since the transaction closed, Parr said the company has "executed a methodical, step-by-step plan to increase revenues by consolidating sales channels and defining an industry-leading continuum of CAD products. We have also taken steps to reduce projected operating costs by approximately $4 million on an annualized basis."

In the first quarter of 2004, iCAD began to cut costs with the closure of offices in Tampa, Fla., and San Rafael, Calif., as well as reducing staffing and eliminating duplication in marketing, administrative and other activities. Those actions and others are expected to reduce operating costs by approximately $4 million annually.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup